Literature DB >> 16497640

Intracranial germinoma: a rare but important differential diagnosis in children with growth retardation.

Sven Gottschling1, Norbert Graf, Sascha Meyer, Harald Reinhard, Thomas Krenn, Tilman Rohrer.   

Abstract

AIM: Intracranial germinoma is a rare malignant tumour in childhood with an excellent prognosis under adequate therapy. Finding the right diagnosis at an early stage is difficult because of the slow-growing tumour and the resulting lack of clinical symptoms.
METHODS: Our patients with histologically secured germinoma were retrospectively assessed concerning growth retardation, pituitary hormone status, magnetic resonance imaging scan results and clinical symptoms to find out whether there is a leading parameter.
RESULTS: In all our patients, the leading symptom was growth retardation of at least 2 y before being diagnosed.
CONCLUSION: Growth retardation seems to be a very early sign of germinoma in the suprasellar region. Therefore, early neuroradiological imaging combined with pituitary hormone status should be considered in every paediatric patient with a history of secondary growth retardation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497640     DOI: 10.1080/08035250500430262

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis.

Authors:  Vered Shay; Aviva Fattal-Valevski; Liana Beni-Adani; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2011-08-26       Impact factor: 1.475

2.  Effect of Growth Hormone treatment on Height Velocity of Children with Pycnodysotosis.

Authors:  Zohreh Karamizadeh; Homa Ilkhanipoor; Fereshte Bagheri
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

3.  Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.

Authors:  Julia Anttonen; Tiina Remes; Pekka Arikoski; Päivi Lähteenmäki; Mikko Arola; Arja Harila-Saari; Tuula Lönnqvist; Tytti Pokka; Pekka Riikonen; Kirsti Sirkiä; Heikki Rantala; Marja Ojaniemi
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.